Middle market investment bank Harris Williams has advised on the sale of Alma Lasers, a developer, manufacturer and provider of laser, light-based, radio-frequency and ultrasound devices for aesthetic and medical applications, to subsidiaries of Fosun International, a Chinese strategic buyer, for an enterprise value of USD220m.
Harris Williams acted as the exclusive advisor to Alma Lasers, a portfolio company of TA Associates. Somerley, with whom Harris Williams has an exclusive relationship, provided support during this transaction.
The transaction closed on 27 May and was led by Thierry Monjauze, Julien Darmon, Francois Morin and Alex Murrill from Harris Williams’ London office along with Turner Bredrup from the firm’s Healthcare and Life Sciences (HCLS) Group.
“The acquisition of Alma Lasers by Fosun International is the largest technology-focused investment in Israel by a Chinese acquirer and represents a landmark transaction. We were delighted to work with the management of Alma Lasers and TA Associates on the sale. The management team and TA Associates have built an exceptionally high quality platform by focusing on delivering innovative multi-application treatment systems that offer considerable value to aesthetic and medical practitioners,” says Monjauze.
In addition to the sale of Alma Lasers to Fosun International, Harris Williams has completed transactions across the Asia-Pacific region including the sale of Yakima to Kemflo International, Border Foods to Mizkan Group and Stolle Machinery to Toyo Seikan as well as Nippon Life’s minority investment in Best Doctors.
Fosun Group is one of the largest private holding companies in China, with USD25.8bn of total assets and USD12.5bn of assets under management.
